• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Comment on: "Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data".

作者信息

He Zhonghu, Liu Fangfang, Yang Wenlei, Ke Yang

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Genetics, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.

出版信息

Ann Surg. 2022 Dec 1;276(6):e1114-e1115. doi: 10.1097/SLA.0000000000005281. Epub 2021 Nov 9.

DOI:10.1097/SLA.0000000000005281
PMID:35129494
Abstract
摘要

相似文献

1
Response to Comment on: "Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data".对关于《辅助治疗对接受食管切除术的食管鳞状细胞癌患者是否是更好的选择？基于多中心真实世界数据的预后预测模型》评论的回复
Ann Surg. 2022 Dec 1;276(6):e1114-e1115. doi: 10.1097/SLA.0000000000005281. Epub 2021 Nov 9.
2
Comment on: "Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data".
Ann Surg. 2022 Dec 1;276(6):e1114. doi: 10.1097/SLA.0000000000005278. Epub 2021 Nov 9.
3
ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.ASO作者反思：胸段食管鳞状细胞癌患者食管切除术后的预后分层及辅助治疗的价值
Ann Surg Oncol. 2019 Dec;26(Suppl 3):802-803. doi: 10.1245/s10434-019-07728-7. Epub 2019 Oct 25.
4
Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients.食管癌切除术后辅助化疗对食管癌患者有益。
In Vivo. 2019 Mar-Apr;33(2):501-506. doi: 10.21873/invivo.11502.
5
ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.ASO作者反思：新辅助治疗后接受食管鳞状细胞癌次全食管切除术患者的术前凝血状态与预后之间的关联
Ann Surg Oncol. 2024 May;31(5):3473-3474. doi: 10.1245/s10434-024-14979-6. Epub 2024 Jan 23.
6
Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.内镜切除术后 pT1a-m3/pT1b 食管鳞癌的辅助治疗：食管切除术还是放化疗？批判性评价。
Crit Rev Oncol Hematol. 2020 Mar;147:102883. doi: 10.1016/j.critrevonc.2020.102883. Epub 2020 Jan 25.
7
Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.列线图预测根治性食管切除术后胸段食管鳞癌患者的总生存。
Ann Surg Oncol. 2019 Sep;26(9):2890-2898. doi: 10.1245/s10434-019-07393-w. Epub 2019 Jun 10.
8
NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma.NOX4 过表达是接受根治性食管切除术治疗食管鳞癌患者的一个不良预后因素。
Surgery. 2020 Mar;167(3):620-627. doi: 10.1016/j.surg.2019.11.017. Epub 2019 Dec 27.
9
A Potential Indication for Adjuvant Therapy in Node-Negative Esophageal Squamous Cell Carcinoma.淋巴结阴性食管鳞状细胞癌辅助治疗的潜在指征
Ann Surg Oncol. 2020 Oct;27(11):4091-4092. doi: 10.1245/s10434-020-08846-3. Epub 2020 Jul 20.
10
Combined endoscopic-laparoscopic radical esophagectomy and lymph node dissection for the treatment of esophageal squamous cell carcinoma.联合内镜-腹腔镜根治性食管切除术及淋巴结清扫术治疗食管鳞状细胞癌。
Gastrointest Endosc. 2020 Jan;91(1):192-193. doi: 10.1016/j.gie.2019.08.008. Epub 2019 Aug 20.

引用本文的文献

1
Robot-assisted esophagectomy with robot-sewn intrathoracic anastomosis (Ivor Lewis): surgical technique and early results.机器人辅助经胸食管切除术机器人吻合术（Ivor Lewis）：手术技术和早期结果。
Updates Surg. 2023 Jun;75(4):941-952. doi: 10.1007/s13304-022-01439-7. Epub 2022 Dec 12.
2
Implementation of the robotic abdominal phase during robot-assisted minimally invasive esophagectomy (RAMIE): results from a high-volume center.机器人辅助微创食管切除术（RAMIE）中机器人腹部阶段的实施：来自大容量中心的结果。
Surg Endosc. 2023 Feb;37(2):1357-1365. doi: 10.1007/s00464-022-09681-1. Epub 2022 Oct 6.
3
ASO Author Reflections: A Novel Blood-Based Predictor (MF-A) That Independently Influences the Prognosis of ESCC Patients Receiving Esophagectomy.
Ann Surg Oncol. 2022 Sep;29(9):5634-5635. doi: 10.1245/s10434-022-11428-0. Epub 2022 Jul 11.
4
Propensity-Matched Analysis of the Short-Term Outcome of Robot-Assisted Minimally Invasive Esophagectomy Versus Conventional Thoracoscopic Esophagectomy in Thoracic Esophageal Cancer.机器人辅助微创与传统胸腔镜食管癌根治术治疗胸段食管癌近期疗效的倾向性匹配分析。
World J Surg. 2022 Aug;46(8):1926-1933. doi: 10.1007/s00268-022-06567-0. Epub 2022 Apr 30.
5
Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma.联合平均红细胞血红蛋白量、纤维蛋白原和白蛋白（MF-A）是可切除食管鳞癌患者的一种新的预后标志物。
Ann Surg Oncol. 2022 Sep;29(9):5626-5633. doi: 10.1245/s10434-022-11415-5. Epub 2022 Feb 18.